Home JC Medical Inc.

JC Medical Inc.

JC Medical Announces the First Successful Treatment in the US with the J-Valve TAVR Device

1/7/19: “The J-Valve TF system has specific attributes that differentiate it from all other currently available TAVR systems, which I believe will enhance the safety and efficacy of TAVR for the indications of aortic valvular insufficiency (regurgitation) and possibly valve-in valve replacement of failing surgically implanted bioprosthetic valves,” said Dr. Kereiakes. “J-Valve was clearly the best treatment option for our patient.”